Reuters logo
ARYx Therapeutics files for $86.25 million IPO
August 30, 2007 / 9:47 PM / 10 years ago

ARYx Therapeutics files for $86.25 million IPO

WASHINGTON, Aug 30 (Reuters) - Biopharmaceutical company ARYx Therapeutics Inc filed with regulators on Thursday to raise up to $86.25 million in an initial public offering of common stock.

The company said in a registration statement with the U.S. Securities and Exchange Commission that Morgan Stanley, CIBC World Markets, Jefferies and Co, and Leerink Swann & Co are underwriting the IPO.

ARYx has applied to list its stock on Nasdaq under the symbol “ARYX” ARYX.O.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below